Table 1:
Evaluation on COPD dataset
| Method | Supervised | logFEV1pp | logFEV1/FVC | GOLD | CLE | Para-septal | AE History | Future AE | mMRC |
|---|---|---|---|---|---|---|---|---|---|
| Metric | R-Square | % Accuracy | |||||||
| LAA-950 | ✗ | 0.44±.02 | 0.60±.01 | 55.8 | 32.9 | 33.3 | 73.8 | 73.8 | 41.6 |
| K-Means | ✗ | 0.55±.03 | 0.68±.02 | 57.3 | - | - | - | - | - |
| Divergence-based | ✗ | 0.58±.03 | 0.70±.02 | 58.9 | - | - | - | - | - |
| MedicalNet | ✗ | 0.47±.10 | 0.59±.06 | 57.0±1.3 | 40.3±1.9 | 53.1±0.7 | 78.7±1.3 | 81.4±1.7 | 47.9±1.2 |
| ModelsGenesis | ✗ | 0.58±.01 | 0.64±.01 | 59.5±2.3 | 41.8±1.4 | 52.7±0.5 | 77.8±0.8 | 76.7±1.2 | 46.0±12 |
| MoCo | ✗ | 0.40±.02 | 0.49±.02 | 52.7±1.1 | 36.5±0.7 | 52.5±1.4 | 78.6±0.9 | 82.0 ±1.2 | 46.4±1.7 |
| 2D CNN | ✓ | 0.53 | - | 51.1 | - | - | 60.4 | - | - |
| Subject2Vec | ✓ | 0.67 ±.03 | 0.74 ±.01 | 65.4 | 40.6 | 52.8 | 76.9 | 68.3 | 43.6 |
| Ours w/o CE | ✗ | 0.56±.03 | 0.65±.03 | 61.6±1.2 | 48.1±0.4 | 55.5±0.8 | 78.8 ±1.2 | 80.8±1.7 | 50.4±1.0 |
| Ours w/o Graph | ✗ | 0.60±.01 | 0.69±.01 | 62.5±1.0 | 49.2±1.1 | 55.8±1.3 | 78.7±1.5 | 80.7±1.7 | 50.6±0.8 |
| Ours | ✗ | 0.62±.01 | 0.70±.01 | 63.2±1.1 | 50.4 ±1.3 | 56.2 ±1.1 | 78.8 ±1.3 | 81.1±1.6 | 51.0 ±1.0 |
- indicates not reported.